Zephyrnet Logo

Tag: SARS

Operational Considerations for Maintaining Essential Services and Providing Prevention, Care, and Treatment for Tuberculosis (TB) in Low-Resource non-US Settings During the COVID-19 Pandemic

IntroductionDespite being preventable and curable, tuberculosis (TB) remains the world’s deadliest infectious disease, taking the lives of 1.5 million persons each year. One-fourth...

Dr. Fauci’s NIH approved hydroxychloroquine 15 years ago to cure coronaviruses. So what’s changed?

On August 8, New York Post wrote a piece about New York City Councilman Paul Vallone who recently recovered from coronavirus after treatment...

Financial Regulators Update Guidance for Hemp-Related Business Banking: Seven Key Points

As the hemp-related product industry continues to grow, institutional lenders now have clarifying guidance to consider as they conduct diligence regarding potential borrowers....

Ten COVID-19 Tests a Month, Salaries Unpaid, a 75% Pay-Cut: Real Story of a Pilot

I am an Air India pilot.You will never know my name. Not because I am scared to tell you who I am, but...

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

According to a study published in Nature Biotechnology, the sVNT is capable of detecting the functional neutralizing antibodies (NAbs) that can block the...

Low Cost COVID-19 Test Kit, “Corosure” Launched By IIT Delhi

--Sharing is Caring-- IIT-Delhi’s COVID19 Test Kit LaunchedThe Indian Institute of Technology (IIT) Delhi has developed and launched a low-cost COVID-19 test kit...

COVID-19 vaccine development and a potential nanomaterial path forward

1.Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel coronavirus outbreak of global health concern. Lancet 395, 470–473...

THSTI Files Patent For Peptide-Based Vaccine Candidates Against SARS-CoV-2 Virus

--Sharing is Caring-- THSTI Files Patent for Peptide-based COVID-19 Vaccine CandidateTranslational Health Science and Technology Institute (THSTI) files patent for SARS-COV2 spike domain...

Global wildlife surveillance could provide early warning for next pandemic

The virus that causes COVID-19 probably originated in wild bats that live in caves around Wuhan, China, and may have been passed to...

World’s First Triple Antigen VLP COVID-19 Vaccine Candidate Enters Animal Trials

--Sharing is Caring-- Premas Biotech’s COVID19 Vaccine Candidate Enters Animal TrialsPremas Biotech’s triple antigen VLP COVID-19 vaccine candidate enters animal trialsThe world’s first...

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from Bpifrance. The funding will be used to develop...

How Immuno-Oncology Contributes to the Fight Against Covid-19

As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for developing new treatments for infectious diseases by harnessing...

Latest Intelligence

spot_img
spot_img